Alpha-9 Oncology
Harnessing the power of radiopharmaceuticals
Alpha-9 Oncology was founded in 2019, is headquartered in Vancouver, Canada, lists 51–200 employees, and has $257.8M in recorded funding across 4 rounds.
- Headquarters
- Vancouver
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- a9oncology.com
- Total Funding
- $257.8M
- Last Round
- $175.0M Series COct 2024
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 8 investors for this company. The full record is or through the API.
About
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company advancing a distinctive portfolio of bespoke, targeted molecules to treat cancer cells with unparalleled precision. The company employs an iterative process to optimize each part of the molecule — binder, linker, chelator, and radioisotope — supported by state-of-the-art infrastructure and in-house formulation expertise. Alpha-9 is backed by top-tier investors with Phase 1 studies underway, including A9-3408, an Actinium-225-based radiotherapeutic. Headquartered in Vancouver, BC with a U.S. office in Boston, MA.
Summary
Alpha-9 Oncology is a Life Sciences company based in Vancouver, Canada, founded in 2019. It lists 51–200 employees. It has raised $257.8M in total across 4 rounds, most recently a $175.0M Series C round in Oct 2024. Investors include Lightspeed Venture Partners, Ascenta Capital and Nextech Invest.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2024
Sign up to see all 4 events
Funding: Seed through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alpha-9-oncology"><img src="https://indexed.vc/api/badge/company/alpha-9-oncology" alt="Alpha-9 Oncology on Indexed.vc" width="260" height="76" /></a>